The city of Baton Rouge, Louisiana, currently has 4 active clinical trials seeking participants for Diabetes research studies.
Assessing the Value of Avocados on Glycemic Control in Type 2 Diabetes
Recruiting
The objective of this study is to assess the effects of Hass Avocados on glycemic control. The investigators hypothesize that Hass Avocado consumption will reduce fasting blood sugar compared to an isocaloric amount of other fruit during controlled feeding.
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
12/12/2024
Locations: Pennington Biomedical Research Center, Baton Rouge, Louisiana
Conditions: Diabetes Mellitus, Type 2, Insulin, Fructosamine, C-Reactive Protein, Glucose, Overweight and Obesity
Military Health and Nutrition Examination Study
Recruiting
The Military Health and Nutrition Examination Study (MHANES) is a Department of Defense funded study conducted by Pennington Biomedical Research Center and the US Army Research Institute of Environmental Medicine. This cross-sectional study will assess, in a large, diverse sample of Army Service Members (n=600), food and supplement intake, cardiovascular health, body composition, biomarkers of nutritional status, measures of health status, injury prevalence, mental wellbeing, gut microbiome comp... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/23/2024
Locations: Pennington Biomedical Research Center, Baton Rouge, Louisiana
Conditions: Hypertension, Type 2 Diabetes, Dyslipidemias, Cardiovascular Diseases
Evaluating Glial Acetate Metabolism as a Biomarker of Hypoglycemic Counterregulation
Recruiting
Hypoglycemic complications are a major impediment to the maintenance of healthy glucose levels in persons with diabetes. The investigators recently completed a clinical pilot and feasibility study (GLIMPSE, NCT02690168), which identified a novel biomarker, glial acetate metabolism, that appears to predict the susceptibility to hypoglycemia. By providing an assay to predict hypoglycemic events and therefore diabetic complications, the development of this biomarker could significantly improve the... Read More
Gender:
ALL
Ages:
Between 18 years and 40 years
Trial Updated:
07/05/2024
Locations: Pennington Biomedical Research Center, Baton Rouge, Louisiana
Conditions: Diabetes, Hypoglycemia
Treatment to Regress to Normoglycemia in Women With a Recent History of GDM
Recruiting
The purpose of the study is to determine the efficacy of semaglutide 1mg (OzempicĀ®) to aid recently postpartum women with dysglycemia and a history of GDM to regress to normoglycemia; thereby filling a gap in efficacious pharmacologic intervention options for clinicians to support postpartum diabetes recovery and reduce future risk of T2DM in young women.
Gender:
Female
Ages:
Between 18 years and 45 years
Trial Updated:
01/18/2024
Locations: Woman's Hospital, Baton Rouge, Louisiana
Conditions: Pre Diabetes, Postpartum Disorder